Skip to main content
. 2020 Jan;18(1):179–187.e6. doi: 10.1016/j.cgh.2019.05.013

Figure 1.

Figure 1

Change in liver biochemistry over time on vedolizumab. The median, IQR, and range are shown. The number of patients with liver biochemistry values and therefore included in the analyses are shown for each timepoint above the corresponding box and whiskers plot. Wilcoxon matched-pairs signed rank test was performed. VDZ, vedolizumab. ns = P > .05; *P ≤ .05; **P ≤ .01; ***P ≤ .001.